Biotricity is trading at $0.05, down 9.09%, with no verified catalyst identified for the decline. - No company-specific announcement dated October 15 or 16, 2026, or verified explanation was found in Biotricity’s news room. - The Nasdaq is down 0.58%, while the Dow is up 0.63%; healthcare is also reported up, and these trends do not clearly explain the drop. - Earlier volatility is not evidence of a cause.